Search research articles
Contact Us
Filters
Showing results (21-30 of 76) with videos related to
Page
of 8
Sort By:
Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care
|
November 7, 2022
Cost Analysis of Buprenorphine Extended-Release Injection Versus Sublingual Buprenorphine/Naloxone Tablets in a Correctional Setting
James S H Wong, Sarah Masson, Alan Huang, et al.
Experimental & Molecular Medicine
|
November 25, 2020
FGF401 and vinorelbine synergistically mediate antitumor activity and vascular normalization in FGF19-dependent hepatocellular carcinoma
Hung Huynh, Aldo Prawira, Thi Bich Uyen Le, et al.
Hepatology (Baltimore, Md.)
|
December 22, 2018
Infigratinib Mediates Vascular Normalization, Impairs Metastasis, and Improves Chemotherapy in Hepatocellular Carcinoma
Hung Huynh, Liek Yeow Lee, Kah Yong Goh, et al.
Canadian Journal of Gastroenterology & Hepatology
|
July 23, 2016
Hepatitis B Awareness and Knowledge in Asian Communities in British Columbia
Alan Hoi Lun Yau, Jo-Ann Ford, Peter Wing Cheung Kwan, et al.
Medicine
|
September 10, 2022
Incidence risk of peripheral edema in cancer patients treated with PD-1/PD-L1 inhibitors: A PRISMA guideline systematic review and meta-analysis
Yuan Tian, Alan Huang, Mei Tian, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 7, 2009
Discovery and optimization of CRTH2 and DP dual antagonists
Jiwen Liu, Zice Fu, Yingcai Wang, et al.
Journal of Medicinal Chemistry
|
May 18, 2026
The Discovery of TNG456: A Highly Potent, Selective, Brain-Penetrant MTA-Cooperative PRMT5 Inhibitor for the Treatment of <i>MTAP</i>-Deleted Cancers
Kevin M Cottrell, Kimberly J Briggs, Alice Tsai, et al.
Cell Cycle (Georgetown, Tex.)
|
January 30, 2009
Single-vector inducible lentiviral RNAi system for oncology target validation
Dmitri Wiederschain, Susan Wee, Lin Chen, et al.
Journal of Medicinal Chemistry
|
February 7, 2025
MTA-Cooperative PRMT5 Inhibitors: Mechanism Switching Through Structure-Based Design
Kevin M Cottrell, Douglas A Whittington, Kimberly J Briggs, et al.
Cancer Discovery
|
February 13, 2015
FGFR-Mediated Reactivation of MAPK Signaling Attenuates Antitumor Effects of Imatinib in Gastrointestinal Stromal Tumors
Fang Li, Hung Huynh, Xiaoyan Li, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 76) with videos related to
Sort By:
Page
of 8
Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care
|
November 7, 2022
Cost Analysis of Buprenorphine Extended-Release Injection Versus Sublingual Buprenorphine/Naloxone Tablets in a Correctional Setting
James S H Wong, Sarah Masson, Alan Huang, et al.
Experimental & Molecular Medicine
|
November 25, 2020
FGF401 and vinorelbine synergistically mediate antitumor activity and vascular normalization in FGF19-dependent hepatocellular carcinoma
Hung Huynh, Aldo Prawira, Thi Bich Uyen Le, et al.
Hepatology (Baltimore, Md.)
|
December 22, 2018
Infigratinib Mediates Vascular Normalization, Impairs Metastasis, and Improves Chemotherapy in Hepatocellular Carcinoma
Hung Huynh, Liek Yeow Lee, Kah Yong Goh, et al.
Canadian Journal of Gastroenterology & Hepatology
|
July 23, 2016
Hepatitis B Awareness and Knowledge in Asian Communities in British Columbia
Alan Hoi Lun Yau, Jo-Ann Ford, Peter Wing Cheung Kwan, et al.
Medicine
|
September 10, 2022
Incidence risk of peripheral edema in cancer patients treated with PD-1/PD-L1 inhibitors: A PRISMA guideline systematic review and meta-analysis
Yuan Tian, Alan Huang, Mei Tian, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 7, 2009
Discovery and optimization of CRTH2 and DP dual antagonists
Jiwen Liu, Zice Fu, Yingcai Wang, et al.
Journal of Medicinal Chemistry
|
May 18, 2026
The Discovery of TNG456: A Highly Potent, Selective, Brain-Penetrant MTA-Cooperative PRMT5 Inhibitor for the Treatment of <i>MTAP</i>-Deleted Cancers
Kevin M Cottrell, Kimberly J Briggs, Alice Tsai, et al.
Cell Cycle (Georgetown, Tex.)
|
January 30, 2009
Single-vector inducible lentiviral RNAi system for oncology target validation
Dmitri Wiederschain, Susan Wee, Lin Chen, et al.
Journal of Medicinal Chemistry
|
February 7, 2025
MTA-Cooperative PRMT5 Inhibitors: Mechanism Switching Through Structure-Based Design
Kevin M Cottrell, Douglas A Whittington, Kimberly J Briggs, et al.
Cancer Discovery
|
February 13, 2015
FGFR-Mediated Reactivation of MAPK Signaling Attenuates Antitumor Effects of Imatinib in Gastrointestinal Stromal Tumors
Fang Li, Hung Huynh, Xiaoyan Li, et al.
Page
of 8